LifeMD, Inc.
LFMD Nasdaq· Services-Offices & Clinics Of Doctors Of Medicine
Last close · Oct 26, 2026
$2.08
KIRA · Stoqly’s AI analyst, in plain words
- LifeMD, Inc. had $194M of revenue in fiscal 2025, up 25.3% on the year before. Over five years, revenue changed +39.1% a year on average.
- Its operating margin was −4.0%, up 9.2 pts: of every 100 in sales, about −4 is left after running the business.
- LifeMD, Inc. made $14.4M of net profit in fiscal 2025.
- Free cash flow was $6.4M in fiscal 2025, 3.3% of revenue.
- LifeMD, Inc. returned $3.4M to shareholders in fiscal 2025, 53% of free cash flow. The diluted share count rose 9.5%.
Market cap
$99.4M
P/E
8.3x
Revenue
$194M
Net income
$14.4M
Free cash flow
$6.4M
Operating margin
−4.0%
LifeMD, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+25.3%
Yes. Sales grew 25.3% last year.
Does it make a profit?
7.4%
A little. It keeps 7.4% of every sale as profit.
Does profit turn into cash?
3.3%
Partly. 3.3% of sales ends up as free cash.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
8.3x
One share costs 8.3 times its yearly profit per share.
What LifeMD, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 10, 2026
- Legal name
- LifeMD, Inc.
- CIK
- 0000948320
LifeMD, Inc. · LFMD
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $92.9M | $119M | $153M | $155M | $194M |
| Revenue growth | 149.0% | 28.2% | 28.2% | 1.5% | 25.3% |
| Gross margin | 80.6% | 84.3% | 87.6% | 86.2% | 85.7% |
| Operating margin | −58.5% | −36.5% | −9.5% | −13.2% | −4.0% |
| Net income | −$60.9M | −$45.5M | −$20.6M | −$21.4M | $14.4M |
| Net margin | −65.6% | −38.3% | −13.5% | −13.8% | 7.4% |
| Diluted EPS | — | — | — | −$0.60 | $0.25 |
| Cash | |||||
| Cash from operations | −$33.1M | −$22.9M | $8.8M | $17.5M | $8.3M |
| Capital expenditure | $0.2M | $0.4M | $0.2M | $1.5M | $1.9M |
| Free cash flow | −$33.3M | −$23.3M | $8.6M | $16.0M | $6.4M |
| FCF margin | −35.9% | −19.6% | 5.6% | 10.4% | 3.3% |
| Dividends paid | $0.9M | $3.1M | $3.1M | $3.1M | $3.1M |
| Share buybacks | — | — | — | — | $0.3M |
| Share count change | 89.2% | 14.7% | 9.5% | 21.5% | 9.5% |
| Debt and strength | |||||
| Cash and short-term investments | $41.3M | $4.0M | $33.1M | $35.0M | $36.8M |
| Shareholders' equity | $22.7M | −$11.4M | $3.5M | −$9.1M | $23.2M |
| Current ratio | 2.0x | 0.4x | 1.2x | 0.8x | 1.2x |
| Interest coverage | −18.0x | −34.1x | −5.6x | −9.4x | −5.6x |
| Returns and quality | |||||
| Return on equity | −595.9% | −802.8% | — | — | 204.0% |
| Return on tangible equity | −271.9% | — | −4,777.7% | — | 49.1% |
| Piotroski F-score | 4 | 3 | 5 | 3 | 5 |
| Altman Z'' | −12.7 | −41.1 | −12.7 | −13.5 | −9.8 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.1M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
LifeMD, Inc. · LFMD
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $2.08 a share, the company is worth $99.4M: 8.3 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0000948320). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.